05/02/2014 - 6:32am

AstraZeneca rejected Pfizer's $106 billion bid for the company Friday morning.

05/01/2014 - 2:15pm

An effort to raise the federal minimum wage to $10.10 failed on Wednesday, as the issue was not able to clear a procedural vote in the Senate.

04/28/2014 - 1:41pm

Forest Labs and Furiex Pharmaceuticals on Monday announced that Forest will acquire Furiex for $95 per share, or approximately $1.1 billion in cash.

04/28/2014 - 12:03pm

Mylan last week announced that it filed suit against the Food and Drug Administration, challenging the agency's decision regarding generic drug marketing exclusivity on celecoxib capsules, the generic equivalent of Pfizer's Celebrex.

04/28/2014 - 9:05am

U.S. pharmaceutical firm Pfizer this morning confirmed discussions with AstraZeneca regarding a possible merger. If the transaction goes through, it's expected that the two companies will combine under a new U.K-incorporated holding company.

04/24/2014 - 1:47pm

Endo International announced that its affiliates have acquired rights to Sumavel DosePro (sumatriptan injection) for subcutaneous use from Zogenix.

04/24/2014 - 12:13pm

A cough syrup produced by Actavis will no longer be available due to the negative light cast on the product stemming from abuse by musicians like Justin Bieber and Soulja Boy, according to a report from the Huffington Post.

04/24/2014 - 11:28am

The Food and Drug Administration on Thursday proposed a new rule that would extend the agency's tobacco authority to cover additional tobacco products. The proposal is part of the FDA's implementation of the Family Smoking Prevention and Tobacco control Act, which was signed by President Barack Obama in 2009.

04/24/2014 - 9:35am

The Food and Drug Administration on Wednesday approved Sylvant (siltuximab) to treat patients with multicentric Castleman’s disease, a rare disorder similar to lymphoma (cancer of the lymph nodes).